Erectile dysfunction in patients with chronic viral hepatitis: A systematic review of the literature

Expert Opinion on Pharmacotherapy

Volumn 14, Issue 18, 2013, Pages 2533-2544

  Fusco, Ferdinando ^a,b   D'Anzeo, Gianluca ^c   Rossi, Andrea ^c   Sciorio, Carmine ^a   Buonomo, Antonio Riccardo ^b   D'Ammanuele Di Villa Bianca, Roberta ^a,b   Borgia, Guglielmo ^b   Mirone, Vincenzo ^a,b   Gentile, Ivan ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Medical Department   (Italy)

Author keywords

Erectile dysfunction; Hepatitis; Phosphodiesterase type 5 inhibitors; Review; Viral hepatitis

Indexed keywords

ALBINTERFERON ALPHA2B; ALPHA INTERFERON; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOCEPREVIR; CYTOCHROME P450 3A4; DIURETIC AGENT; ESTRADIOL; GAMMA GLUTAMYLTRANSFERASE; GONADOTROPIN; PEGINTERFERON; PEGINTERFERON ALPHA2A; PROLACTIN; RIBAVIRIN; SEX HORMONE; SILDENAFIL; TADALAFIL; TELAPREVIR; TESTOSTERONE; VARDENAFIL;

ALCOHOL ABUSE; ALCOHOL LIVER CIRRHOSIS; ANDROGEN BLOOD LEVEL; ANTIVIRAL THERAPY; ANXIETY; ASTHENIA; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; COMORBIDITY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE CARRIER; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; EJACULATION; END STAGE LIVER DISEASE; ERECTILE DYSFUNCTION; FATIGUE; GONAD DYSFUNCTION; HEPATITIS B; HEPATITIS C; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LIBIDO; LIVER CIRRHOSIS; MALE SEXUAL DYSFUNCTION; MIXED INFECTION; PATHOGENESIS; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL HEALTH; SEXUAL SATISFACTION; SIDE EFFECT; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; VIRUS HEPATITIS;

ANTIVIRAL AGENTS; ERECTILE DYSFUNCTION; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS D, CHRONIC; HUMANS; MALE; PHOSPHODIESTERASE 5 INHIBITORS; TESTOSTERONE;

EID: 84887924285     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2013.850073     Document Type: Review

References (48)

1. NIH consensus development panel on impotence. Impotence. JAMA 1993;270:83-90
2. O'Leary MP, Althof SE, Cappelleri JC, et al. Self-esteem, confidence and relationship satisfaction of men with erectile dysfunction treated with sildenafil citrate: A multicenter, randomized, parallel group, double-blind, placebo controlled study in the United States. J Urol 2006;175:1058-62
3. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61
4. Kaiser FE. Erectile dysfunction in the aging man. Clin North Am 1999;83:1267-78
5. Chung SD, Chen YK, Kang JH, et al. Population-based estimates of medical comorbidities in erectile dysfunction in a Taiwanese population. J Sex Med 2011;8(12):3316-24
6. Broderick GA. Oral pharmacotherapy and the contemporary evaluation and management of erectile dysfunction. Rev Urol 2003;5(Suppl 7):S9-S20
7. WHO Executive Board. Viral hepatitis. Report by the secretariat. EB126/15, 12 November 2009. Available fom http://apps.who.int/gb/ebwha/pdf- files/ EB126/B126-15-en.pdf
8. Ly KN, Xing J, Klevens RM, et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012;156:271-8
9. Katsanos KH, Christodoulou DK, Zervou E, et al. Hepatitis B remains a major health priority in Western Balkans: Results of a 4-year prospective Greek-Albanian collaborative study. Eur J Intern Med 2009;20:698-702
10. Kwong JC, Ratnasingham S, Campitelli MA, et al. The impact of infection on population health: Results of the Ontario burden of infectious diseases study. PLoS ONE 2012;7:e44103
11. Danoff A, Khan O, Wan DW, et al. Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life. Am J Gastroenterol 2006;101:1235-43
12. Toda K, Miwa Y, Kuriyama S, et al. Erectile dysfunction in patients with chronic viral liver disease: Its relevance to protein malnutrition. J Gastroenterol 2005;40:894-900
13. Chung SD, Keller JJ, Liang YC, et al. Association between viral hepatitis and erectile dysfunction: A population-based case-control analysis. J Sex Med 2012;9:1295-302
14. Durazzo M, Premoli A, Di Bisceglie C, et al. Alterations of seminal and hormonal parameters: An extrahepatic manifestation of HCV infection? World J Gastroenterol 2006;12:3073-6
15. Zani C, Pasquale L, Bressanelli M, et al. The epidemiological pattern of chronic liver diseases in a community undergoing voluntary screening for hepatitis B and C. Dig Liver Dis 2011;43:653-8
16. Guadagnino V, Stroffolini T, Rapicetta M, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy. Hepatology 1997;26:1006-11
17. Di Stefano R, Stroffolini T, Ferraro D, et al. Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission. J Med Virol 2002;67:339-44
18. Wang YJ, Wu JC, Lee SD, et al. Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: A matched study with alcoholic cirrhotic men. Hepatogastroenterol 1991;38:531-4
19. Simsek I, Aslan G, Akarsu M, et al. Assessment of sexual functions in patients with chronic liver disease. Int J Impot Res 2005;17:343-5
20. Soykan A, Boztaş H, Idilman R, et al. Sexual dysfunctions in HCV patients and its correlations with psychological and biological variables. Int J Impot Res 2005;17:175-9
21. Huyghe E, Kamar N, Wagner F, et al. Erectile dysfunction in end-stage liver disease men. J Sex Med 2009;6:1395-401
22. Sorrell JH, Brown JR. Sexual functioning in patients with end-stage liver disease before and after transplantation. Liver Transpl 2006;12:1473-7
23. Ferri C, Bertozzi MA, Zignego AL. Erectile dysfunction and hepatitis C virus infection. JAMA 2002;288:698-9
24. Piazza M, Tosone G, Borgia G, et al. Long-Term interferon-Alpha therapy does not affect sex hormones in males with chronic hepatitis C. J Interferon Cytokine Res 1997;17(9):525-9
25. Conjeevaram HS, Fried MW, Jeffers LJ, et al. Virahep-C Study Group. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 2006;131:470-7
26. Dove LM, Rosen RC, Ramcharran D, et al. Virahep-C Study Group. Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C. Gastroenterol 2009;137:873-84
27. Malaguarnera M, Vicari E, Calogero A, et al. Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin. J Interferon Cytokine Res 2008;28:603-9
28. Kraus MR, Schäfer A, Bentink T, et al. Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: Interferon-induced functional androgen deficiency or depression? J Endocrinol 2005a;185:345-52
29. Kraus MR, Schäfer A, Csef H, et al. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C. World J Gastroenterol 2005b;11:1769-74
30. Gluud C, Wantzin P, Eriksen J. No effect of oral testosterone treatment on sexual dysfunction in alcoholic cirrhotic men. Gastroenterol 1988;95:1582-7
31. Van Thiel DH, Gavaler JS, Sanghvi A. Recovery of sexual function in abstinent alcoholic men. Gastroenterology 1982;84:677-82
32. Schiavi RC, Schreiner-Engel P, White D, et al. The relationship between pituitarygonadal function and sexual behavior in healthy aging men. Psychosom Med 1991;55:363-74
33. Charles ED, Dustin LB. Hepatitis C virus-induced cryoglobulinemia. Kidney Int 2009;76:818-24
34. Hatzimouratidis K, Amar E, Eardley I, et al. European Association of Urology. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur Urol 2010;57:804-14
35. Tadalafil [summary of product characteristics]. Available from: Http:// www.ema.europa.eu/docs/en-GB/ document-library/ EPAR-Product-Information/human/ 000436/WC500026318.pdf [Last accessed 1 June 2012]
36. Sildenafil [summary of product characteristics]. Available from: Http:// www.emea.europa.eu/docs/en-GB/ document-library/ EPAR-Product-Information/human/ 000202/WC500049830.pdf [Last accessed 1 June 2012]
37. Vardenafil [summary of product characteristics]. Available from: Http:// www.ema.europa.eu/docs/en-GB/ document-library/ EPAR-Product-Information/human/ 000475/WC500039992.pdf [Last accessed 7 February 2011]
38. Bociprevir [summary of product characteristics]. Available from: Http:// www.merck.com/product/usa/ pi-circulars/v/victrelis/victrelis-pi.pdf [Last accessed 7 November 2012]
39. Telaprevir [summary of product characteristics]. Available from: Http:// www.janssen.com.au/files/Products/ Incivo-PI.pdf [Last accessed 7 November 2012]
40. Hallinan R, Byrne A, Agho K, et al. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl 2009;32(2):131-9
41. Bliesener N, Albrecht S, Schwager A, et al. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 2005;90(1):203-6
42. Williams VS, Edin HM, Hogue SL, et al. Prevalence and impact of antidepressant-Associated sexual dysfunction in three European countries: Replication in a cross-sectional patient survey. J Psychopharmacol 2010;24(4):489-96
43. Rosen RC, Cappelleri JC, Gendrano N III. The International Index of Erectile Function (IIEF): A state-ofthe-science review. Int J Impot Res 2002;14(4):226-44
44. European Association for the Study of the Liver. EASL clinical practice guidelines: Management of hepatitis C virus infection. J Hepatol 2011;55:245-64
45. Ghany MG, Strader DB, Thomas DL, et al. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 2009;49:1335-74
46. Wespes E, Amar E, Eardley I, et al. Members of the European Association of Urology (EAU) Guidelines Office. Guidelines on Male Sexual Dysfunction: Erectile dysfunction and premature ejaculation In: EAU Guidelines. Edition presented at the 27th EAU Annual Congress, European Association of Urology; Paris: 2012
47. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002;36(Suppl 1):S237-44
48. Corssmit EP, Endert E, Sauerwein HP, et al. Acute effects of interferon-Alpha administration on testosterone concentrations in healthy men. Eur J Endocrinol 2000;143:371-4